Cargando…

Nephroprotection by SGLT2 Inhibition: Back to the Future?

The introduction of sodium/glucose cotransporter 2 inhibitors (SGLT2i) has opened new perspectives for the management of diabetic population at risk of or with chronic kidney disease (CKD). More important, recent, large real-world studies have repositioned the nephroprotective efficacy of SGLT2i eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Nicola, Luca, Gabbai, Francis B., Garofalo, Carlo, Conte, Giuseppe, Minutolo, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408701/ https://www.ncbi.nlm.nih.gov/pubmed/32679744 http://dx.doi.org/10.3390/jcm9072243

Ejemplares similares

SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects
por: Garofalo, Carlo, et al.
Publicado: (2019)

Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
por: Garofalo, Carlo, et al.
Publicado: (2018)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis
por: Garofalo, Carlo, et al.
Publicado: (2023)

Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?
por: Cupisti, Adamasco, et al.
Publicado: (2020)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report
por: Nappi, Felice, et al.
Publicado: (2019)

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
por: De Nicola, Luca, et al.
Publicado: (2012)

Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
por: De Nicola, Luca, et al.
Publicado: (2022)

Resistant Hypertension in Nondialysis Chronic Kidney Disease
por: Borrelli, Silvio, et al.
Publicado: (2013)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care
por: De Nicola, Luca, et al.
Publicado: (2015)

New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study
por: Minutolo, Roberto, et al.
Publicado: (2022)

The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients
por: Zoccali, Carmine, et al.
Publicado: (2023)

New Insights into the Nephroprotective Potential of Lercanidipine
por: Hajdys, Joanna, et al.
Publicado: (2023)

Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study
por: Minutolo, Roberto, et al.
Publicado: (2021)

Ovarian Drilling: Back to the Future
por: Mercorio, Antonio, et al.
Publicado: (2022)

Mechanisms of Herbal Nephroprotection in diabetes mellitus
por: Dragoș, Dorin, et al.
Publicado: (2020)

SGLT2 inhibition to address the unmet needs in diabetic nephropathy
por: Barutta, Federica, et al.
Publicado: (2019)

Mineral and Electrolyte Disorders With SGLT2i Therapy
por: Cianciolo, Giuseppe, et al.
Publicado: (2019)

Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care
por: Borrelli, Silvio, et al.
Publicado: (2018)

Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed
por: Borrelli, Silvio, et al.
Publicado: (2021)

The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective
por: Muscoli, Saverio, et al.
Publicado: (2022)

Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future
por: Iacobini, Carla, et al.
Publicado: (2021)

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
por: Bode, David, et al.
Publicado: (2021)

HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)

The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection
por: Bartnicki, Piotr, et al.
Publicado: (2013)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
por: Salvatore, Teresa, et al.
Publicado: (2022)

Nephroprotective Plants: A Review on the Use in Pre-Renal and Post-Renal Diseases
por: Tienda-Vázquez, Mario Adrián, et al.
Publicado: (2022)

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
por: Górriz, Jose Luis, et al.
Publicado: (2015)

Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care
por: Provenzano, Michele, et al.
Publicado: (2018)

Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes
por: Iijima, Yasuhiro, et al.
Publicado: (2023)

Back to the Future for Influenza Preimmunity—Looking Back at Influenza Virus History to Infer the Outcome of Future Infections
por: Francis, Magen Ellen, et al.
Publicado: (2019)

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
por: Pitt, Bertram, et al.
Publicado: (2022)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
por: Ghezzi, Chiara, et al.
Publicado: (2018)

Nephroprotective Potential of Human Albumin Infusion: A Narrative Review
por: Wiedermann, Christian J., et al.
Publicado: (2015)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Nephroprotective, cytotoxic and antioxidant activities of Euphorbia paralias
por: Al-Yousef, Hanan M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t67i2ek0flpcveik4e81t131sm